Results 121 to 130 of about 2,252,568 (262)

Changes in height standard deviation scores during early life are affected by nutrition. [PDF]

Pediatr Int, 2021
Tanaka T, Kato N, Yokoya S, Ono A, Isojima T, Yokomichi H, Yamagata Z, Tanaka S, Matsubara H, Ishikuro M, Kikuya M, Chida S, Hosoya M, Kuriyama S, Kure S.   +14 more
europepmc   +1 more source

Dofetilide Initiation and Implications of Deviation From the Standard Protocol – A Real World Experience

, 2019
Tawseef Dar, Ghulam Murtaza, Bharath Yarlagadda, Bader Madoukh, Lesley Bravin, Venkat Vuddanda, Valay Parikh, Madhu Reddy, Dhanunjaya Lakkireddy   +8 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

The speed standard deviation in heavy fog under various speed limits.

Rui Chen (95310), Xiaolei He (7133921)
openalex   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Simplified Optimal Estimation of Time-Varying Electromyogram Standard Deviation (EMGσ): Evaluation on Two Datasets. [PDF]

Sensors (Basel), 2021
Wang H, Rajotte KJ, Wang H, Dai C, Zhu Z, Huang X, Clancy EA.   +6 more
europepmc   +1 more source

Bootstrap BCa confidence intervals for a standardized mean difference in a paired samples design using a pooled standard deviation [PDF]

Douglas A. Fitts
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

The Unsupervised Feature Selection Algorithms Based on Standard Deviation and Cosine Similarity for Genomic Data Analysis. [PDF]

Front Genet, 2021
Xie J, Wang M, Xu S, Huang Z, Grant PW.
europepmc   +1 more source